ChiCTR2600118005 版本V1.0 版本创建时间2026/01/30 17:39:16 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600118005 

最近更新日期:

Date of Last Refreshed on:

2026-01-30 17:39:09 

注册时间:

Date of Registration:

2026-01-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

老年非静脉曲张性急性上消化道出血继发急性心梗的模型建构

Public title:

Development of a Prediction Model for Secondary Acute Myocardial Infarction in Elderly Patients with Acute Non-variceal Upper Gastrointestinal Bleeding?

注册题目简写:

English Acronym:

研究课题的正式科学名称:

老年非静脉曲张性急性上消化道出血患者发生继发急性心肌梗死风险模型的建构与验证

Scientific title:

Development and Validation of a Risk Prediction Model for Secondary Acute Myocardial Infarction in Elderly Patients with Acute Non-variceal Upper Gastrointestinal Bleeding

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

关雪 

研究负责人:

关雪 

Applicant:

Xue Guan 

Study leader:

Xue Guan 

申请注册联系人电话:

Applicant telephone:

+86 10 89999009

研究负责人电话:

Study leader's telephone:

+86 13261393402

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

gx19950127@163.com

研究负责人电子邮件:

Study leader's E-mail:

gx19950127@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市平谷区新平北路59号

研究负责人通讯地址:

北京市平谷区新平北路59号

Applicant address:

59 Xinping North Road, Pinggu District, Beijing, China

Study leader's address:

No. 59 Xinping North Road, Pinggu District, Beijing , China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京市平谷区医院

Applicant's institution:

Beijing Pinggu Hospital

研究负责人所在单位:

北京市平谷区医院

Affiliation of the Leader:

Beijing Friendship Hospital Pinggu Campus,Capital Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025-科072-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京市平谷区医院医学伦理委员会

Name of the ethic committee:

Beijing pinggu Hospital Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2025-11-27 00:00:00

伦理委员会联系人:

赵翠伶

Contact Name of the ethic committee:

Zhao CuiLing

伦理委员会联系地址:

北京市平谷区新平北路59号

Contact Address of the ethic committee:

No. 59 Xinping North Road, Pinggu District, Beijing , China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 89978829

伦理委员会联系人邮箱:

Contact email of the ethic committee:

13693052773@163.com

研究实施负责(组长)单位:

北京市平谷区医院

Primary sponsor:

Beijing Friendship Hospital Pinggu Campus,Capital Medical University

研究实施负责(组长)单位地址:

北京市平谷区新平北路59号

Primary sponsor's address:

No. 59 Xinping North Road, Pinggu District, Beijing , China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京市平谷区医院

具体地址:

北京市平谷区新平北路59号

Institution
hospital:

Beijing Friendship Hospital Pinggu Campus,Capital Medical University

Address:

No. 59 Xinping North Road, Pinggu District, Beijing , China

经费或物资来源:

老年非静脉曲张性急性上消化道出血患者发生继发急性心肌梗死风险模型的建构与验证

Source(s) of funding:

Development and Validation of a Risk Prediction Model for Secondary Acute Myocardial Infarction in E

Target disease:

Acute Non-variceal Upper Gastrointestinal Bleeding;Secondary Acute Myocardial Infarction

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

1、分析老年非静脉曲张性急性上消化道出血患者发生继发急性心肌梗死的高危因素和临床转归; 2、构建老年非静脉曲张性急性上消化道出血患者继发急性心肌梗死的列线图预测模型  

Objectives of Study:

1. To analyze the high-risk factors and clinical outcomes of secondary acute myocardial infarction in elderly patients with acute non-variceal upper gastrointestinal bleeding.? 2. To construct a nomogram prediction model for secondary acute myocardial infarction in elderly patients with acute non-variceal upper gastrointestinal bleeding.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.经内镜确诊为病因明确的非静脉曲张性上消化道出血; 2.年龄>=65岁;

Inclusion criteria

1.Diagnosed endoscopically with acute nonvariceal upper gastrointestinal bleeding (ANVUGIB) of a clearly identified cause.
2.Age >=65 years;

排除标准:

1.病史不详、临床资料不完整;
2.发病前尚处于急性心肌梗死或者慢性心肌损伤等肌钙蛋白长期处于升高状态的病例;
3.终末期疾病干扰预后评估;

Exclusion criteria:

1.Unknown medical history and incomplete clinical data;
2.Cases with pre-existing chronically elevated troponin levels, such as those due to acute myocardial infarction (AMI) or chronic myocardial injury;
3.Prognostic assessment is challenging in end-stage disease.

研究实施时间:

Study execute time:

From 2026-01-01 00:00:00 To 2028-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-02-01 00:00:00 To 2027-08-31 00:00:00  

干预措施:

Interventions:

组别:

继发心肌梗死组

样本量:

273

Group:

The secondary myocardial infarction group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

对照组

样本量:

637

Group:

Control Group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京市 

市(区县):

 

Country:

China 

Province:

Beijing 

City:

 

单位(医院):

北京市平谷区医院 

单位级别:

三级医院 

Institution
hospital:

Beijing Friendship Hospital Pinggu Campus,Capital Medical University

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

发生继发性急性心肌梗死

指标类型:

主要指标

Outcome:

Occurrence of secondary acute myocardial infarction

Type:

Primary indicator

测量时间点:

入院后1周

测量方法:

同时满足以下标准:1)心肌肌钙蛋白I动态升高;2)心肌缺血表现(如心悸、胸闷、胸痛、呼吸困难等临床症状,或心电图显示ST段压低、T波低平或倒置、病理性Q波等缺血性改变,或心脏彩超等影像学检查提示心肌缺血改变)。

Measure time point of outcome:

Within 1 week after admission

Measure method:

Inclusion required meeting both of the following criteria: 1) dynamic elevation of cardiac troponin I; and 2) evidence of myocardial ischemia (such as clinical symptoms like palpitations, chest tightness, chest pain, or dyspnea; electrocardiographic findings indicating ischemic changes, such as ST-segment depression, T-wave flattening or inversion, or pathological Q waves; or imaging evidence of myocardial ischemia on modalities like echocardiography).?

指标中文名:

再出血率

指标类型:

次要指标

Outcome:

Rebleeding Rate

Type:

Secondary indicator

测量时间点:

入院后1周

测量方法:

内镜下或症状及辅助检查支持再出血表现

Measure time point of outcome:

Within 1 week after admission

Measure method:

Evidence of rebleeding was supported by endoscopic findings, clinical symptoms, or auxiliary examination results.?

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture, EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-01-30 17:39:09